AGF Investments LLC’s Exact Sciences EXAS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-6,092
Closed -$581K 452
2021
Q3
$581K Buy
6,092
+485
+9% +$51.2K 0.06% 178
2021
Q2
$697K Buy
+5,607
New +$669K 0.07% 72
2018
Q4
Sell
-350
Closed -$28K 730
2018
Q3
$28K Sell
350
-245
-41% -$16K ﹤0.01% 473
2018
Q2
$37 Buy
+595
New +$32K ﹤0.01% 465
2018
Q1
Sell
-376
Closed -$19K 718
2017
Q4
$19K Buy
376
+162
+76% +$8.65K ﹤0.01% 497
2017
Q3
$10K Buy
+214
New +$8.61K ﹤0.01% 520

Other funds holding EXAS

AGF Investments LLC's EXAS Position: Q4 2021 in Review

AGF Investments LLC sold out of Exact Sciences (EXAS) in Q4 2021, closing a stake of 6,092 shares — an estimated $581K sold.

AGF Investments LLC first reported a position in EXAS in Q3 2017 and held it in 6 quarters. The position peaked at $697K in Q2 2021. 596 funds tracked by Wall St. Rank hold EXAS as of Q4 2021.

  • AGF Investments LLC reported no remaining Exact Sciences position as of Q4 2021 after selling out during the quarter.
  • AGF Investments LLC sold 6,092 Exact Sciences shares in Q4 2021, an estimated $581K.
  • AGF Investments LLC first reported a position in Exact Sciences in Q3 2017 and held it in 6 quarters.
  • AGF Investments LLC's Exact Sciences position peaked at $697K in Q2 2021.
  • 596 funds tracked by Wall St. Rank held Exact Sciences as of Q4 2021.

Based on AGF Investments LLC's 13F filing for Q4 2021, filed 1 Feb 2022.